TDZD-8 is a highly selective, non-ATP competitive inhibitor of GSK-3b (IC50=2M). TDZD-8 Binds to the active site of GSK3b. TDZD-8 Does not significantly affect the activities of Cdk-1/cyclin B, CK-II, PKA, and PKC (IC50100M). Potential Alzheimer's treatment.
Research or further manufacturing use only, not for food or drug use.